1. The Role of the UAB Medical Genomics Laboratory in NF Patient Care and Research
  2. Physicians Share Insight about Providing Care to Patients in the UAB Pediatric NF Clinic
  3. UAB NF Program Overview and Updates
  4. A Discussion of Genetic Penetrance and Variability of Expression in NF
  5. A Discussion of Malignant Peripheral Nerve Sheath Tumors (MPNSTs)
  6. Expanding Role of Telemedicine in the UAB NF Clinic
  7. A Discussion of Revised Diagnostic Criteria Released for NF1 and Legius Syndrome
  8. Resuming In-Person UAB NF Clinic Visits and a Discussion of the Frequency of NF Clinic Visits for Pediatric and Adult Patients
  9. COVID-19 Issues for Individuals with NF, Highlights of the UAB NF Symposium Family Day, and NF Clinic News
  10. The Difference in Treatment Options for Plexiform Neurofibromas and Malignant Peripheral Nerve Sheath Tumors
  11. A Discussion of RASopathy Disorders and Potential Treatments with Mechanism-Based Therapies
  12. Virtual UAB NF Symposium Family Day Considered for 2021 and a Discussion of Characteristic Brain MRI Findings in NF1
  13. A Discussion of Genotype/Phenotype Correlations in NF1
  14. FDA Approves Selumetinib as First Treatment for NF1 and a Discussion of MEK Inhibitor-Based Treatments for Plexiform Neurofibromas
  15. Considerations for Individuals with NF Regarding the Novel Coronavirus
  16. The Role of Precision Medicine in NF Diagnosis and Treatment
  17. Highlights from the 2019 NF Conference and ASHG Meeting, Re-Cap of NF Walk, UAB NF Clinic News, and Final Installment of a Review of the Pediatric NF Clinical Care Resource
  18. Upcoming NF Conference and a Review of the Pediatric NF Clinical Care Resource for Neurodevelopmental Problems and Skeletal Abnormalities
  19. UAB NF Symposium Family Day and a Review of Pediatric NF Clinical Care Guidelines for Malignancies and Neurologic Issues Related to NF1
  20. NF Clinic Update and a Review of Pediatric NF Clinical Care Guidelines for Optic Pathway Gliomas and Indications for Neuroimaging in Children with NF1
  21. A Discussion of Newly Published Pediatric NF Clinical Care Guidelines
  22. Approaches to Imaging in the Diagnosis and Management of NF
  23. Explanation of a New Method for Answering NF-Related Email Questions
  24. NF Clinic Adjustments and a Discussion of the Differences Between Schwannomas and Neurofibromas
  25. Multi-Year Research Grants Awarded to UAB Investigators Pursuing Genome-Guided Therapeutics
  26. A Re-Cap of the 2018 NF Conference in Paris
  27. Highlights of Visit with Australian NF Team and Advice for Locating an Experienced NF Program
  28. Upcoming NF Conference and a Final Review of the ACMG Clinical Practice Resource
  29. A Review of ACMG Clinical Practice Resource Related to Hypertension and Vasculopathy, Osteoporosis, and Cutaneous Neurofibromas
  30. A Discussion of ACMG Clinical Practice Resource Related to Tumors Associated with NF1
  31. Highlights of the NF Forum and a Discussion of Newly Published Clinical Care Guidelines for NF1
  32. Highlights of NF Symposium and a Discussion of the Frequency of NF Clinic Visits
  33. A Focus on Improving Our Patients’ Experience and the Relationship Between Atypical Neurofibromas and Malignant Peripheral Nerve Sheath Tumors
  34. New Role as UAB Medicine’s Chief Genomics Officer, Upcoming NF Family Day, and Newly Identified Mutation/Phenotype Correlation in NF
  35. A Re-Cap of the Year’s Endeavors and a Preview of Plans for 2018
  36. Highlights of American Society of Human Genetics Meeting, Alabama NF Walk, and a Discussion of Muscle Involvement in NF1
  37. Recognizing Problems That Require Further Evaluation in Children with NF1
  38. Department of Defense NF Research Program Grant Proposals and a Review of Pain in the Context of NF
  39. Highlights of the 2017 NF Conference, NF Clinical Trials Consortium Update, and Frequently Asked Questions about Clinical Trials
  40. Development of Genome-Guided Therapeutics for NF Based on Genetic Mutation Subsets
  41. Current and Future Research Initiatives for the Treatment of Cutaneous Neurofibromas
  42. Highlights of UAB Rare Disease Genomics Symposium and a Discussion of Visual Screening in Children with NF1
  43. Continued Benefits of NF Clinic Relocations and a Discussion of Headaches in Individuals with NF1
  44. Renewed Grant for the NF Clinical Trials Consortium and a Promising New Drug for the Treatment of NF1
  45. Highlights of a Successful Year and a Look Ahead to New Goals for 2017
  46. Successful Relocation of Adult and Pediatric NF Clinics and a Discussion of Increased Breast Cancer Risk in Women with NF1
  47. A Successful 3rd Annual Alabama NF Walk and a Discussion of Developmental Issues and Cognitive Function in NF1
  48. Highlights of NF Symposium, Plans for 3rd Annual NF Walk, Discussion of Mosaic NF1, and a Review of the NF Neurologic Exam
  49. Upcoming NF Symposium at Children’s Harbor, Applications of New Gene Editing Technology, and a Review of the NF Extremities Exam
  50. NF Clinic Genetics Counselor Receives Esteemed Scholars Award, Re-Cap of NF Forum, and What to Expect During an NF Genital Exam
  51. Upcoming NF Symposium, Enhanced Patient Exam Procedure, and a Review of the NF Abdominal Exam
  52. Sources of Variability in NF and What to Expect During an NF Chest Examination
  53. Re-Cap of Meetings in Washington, DC, for Renewed NF Research Funding and a Review of What to Expect During an NF Neck Exam
  54. New Discoveries in the UAB Medical Genomics Laboratory, Animal Model Progress, and NF-Related Features of the Head
  55. New Year’s Resolutions for the NF Program and Common Skin Issues Detected During an NF Clinic Visit
  56. Animal Model Research Update, Plans for Adult and Pediatric NF Clinics, and the Focus of Exams in an NF Clinic
  57. Successful 2nd Annual Alabama NF Walk and Update on Newly Formed NF Community Advisory Board
  58. Upcoming 2nd Annual Alabama NF Walk and Understanding the Role of NF Genetic Testing
  59. A Successful and Memorable NF Family Day and Plans for Future Dermal Neurofibroma Trials
  60. A New Specialist Joins the NF Clinic Team, Upcoming NF Symposium at UAB, and Understanding RAS Disorders and their Relationship to NF
  61. Understanding Possible Explanations for Isolated Features of NF
  62. Responding to E-mailed Questions from Patients and Reviewing Diagnostic Criteria for Café-Au-Lait Spots and Groin Freckling
  63. Measurement Technique for Dermal Neurofibromas Validated at UAB Expands Possibilities for Clinical Trials
  64. Birmingham Family Affected by NF Recognized at CTF BeNeFit II Gala in Detroit, and Frequently Asked Patient Questions Regarding NF Clinical Trials
  65. Highlights of NF Family Day and Encouraging Developments from an International NF Meeting
  66. Upcoming NF Family Day, Research Advances, and a Special Award for a Birmingham Family Affected by NF
  67. A Successful NF Walk, Two Key NF Conferences, and Rapid Research Progress
  68. A new website and Birmingham's first NF walk